Endoscopic Vessel Harvesting Market Size, Share, and Industry Analysis By Product (Instruments and Accessories), By Application (Coronary Artery Disease (CAD) and Peripheral Artery Disease (PAD)), By Vessel Type (Saphenous Vein and Radial Artery), By End User (Hospitals, Specialty Clinics, and Others), and Regional Forecast till 2032

The global endoscopic vessel harvesting market expands due to the increasing incidence of cardiovascular diseases (CVDs) and the demand for minimally invasive procedures. Endoscopic Vessel Harvesting (EVH) Endoscopic surgery is a minimally invasive procedure that in the cardiovascular and vascular fields is mostly used to harvest a healthy blood vessel, including saphenous vein (VV), radial artery (RA), etc., to use as a conduit in a bypass procedure like Coronary Artery Bypass Grafting (CABG) and other vascular surgery.

The ever-evolving nature of EVH systems is equally playing a key role in the expansion of the markets. Large costs are being incurred by the manufacturers to bring forth new, best devices with superior features. Such advancements have resulted in better visualization (examples include high-definition cameras and near-infrared fluorescence imaging to visualize vessels in real-time), more precise instruments and designs that provide a surgeon more control and performance.

Endoscopic Vessel Harvesting Market Driver

Rising Prevalence of Cardiovascular Diseases (CVDs) to Expand the Market

One of the prime drivers of the EVH market is the rising incidence of cardiovascular diseases, such as coronary artery disease (CAD) and peripheral artery disease (PAD), around the world. The population is growing older, and lifestyle-related issues, including a sedentary lifestyle, poor nutrition, and increasing cases of obesity and diabetes, are becoming prevalent, so the number of people diagnosed with these conditions continues to rise.

Surge in Minimally Invasive Techniques to Advance the Market

The other powerful market driver of the EVH market is a robust and growing trend towards minimally invasive surgical procedures, reinforced by patient preference demands, as well as the clinical advantages. Patients are demanding procedures that produce less post-operative pain, have smaller incisions, result in a smaller chance of scarring, have a lower chance of complications (such as infection and hematoma) and allow them to recover more rapidly, resulting in a shorter hospital stay and a more rapid restoration of normal life.

Endoscopic Vessel Harvesting Market Restraint

High Cost-BurdentoPose Potential Impediments on this Market

Even though Endoscopic Vessel Harvesting (EVH) has substantial clinical benefits, the significant limiting factor behind greater adoption of the technology, especially in under-resourced facilities, is the high cost-burden to initiate use. The initial cost of hospital systems purchasing EVH systems is quite significant, and it involves special endoscopes, cameras, screens, and sets of dedicated, disposable equipment.

Endoscopic Vessel Harvesting Market Opportunity

Size of Emerging Markets to Create Opportunity in this Market

One of the major opportunities of the Endoscopic Vessel Harvesting (EVH) market exists in increasing its markets with the emerging economies. The rise in economy is being noticed in the countries of a region like the Asia-Pacific, Latin America, and the Middle East and Africa, and they are spending more on healthcare, and there is a growing number of the middle-income population, which is now capable of greater medical services.

Segmentation

Key Insights

The report covers the following key insights:

• Market drivers, restraints and opportunities
• Influence of key industrial players and key developments
• Demand for Minimally Invasive Procedures
• Technological Advancements

Analysis by Product

By Product, the Endoscopic Vessel Harvesting market is divided into Instruments & Accessories

The instruments segment includes hard devices and systems that are part of the work of EVH procedures. The EVH instrument market is growing owing to the ever-increasing technological rise.

The growth of the accessories segment is largely prompted by the fact that the volume of EVH procedures performed worldwide is in constant increase, and each of the procedures requires a corresponding set of disposable accessories.

Analysis by Application

Based on Application, the market is divided into Coronary Artery Disease (CAD) & Peripheral Artery Disease (PAD)

This market segment is directly growing as the incidence of CAD globally keeps increasing with the presence of ageing populations, the promotion of high-risk lifestyles, and the onset of chronic conditions such as diabetes and obesity.

Due to the increase of awareness about the benefits offered by EVH in the vascular surgeon's community and the accessibility of the technology, the use of EVH in the treatment of PAD is slowly increasing, hence the overall growth in the EVH market.

Analysis by Vessel Type

Based on Vessel Type, the market is divided into Saphenous Vein & Radial Artery

The saphenous vein, which is normally obtained from the leg, is still the most common medium used in coronary bypass grafting due to its length, easy access, and proper size to be used in bypass.

Although the saphenous vein is still the most in use, the radial artery in the arm has gotten a lot of popularity as an alternative arterial conduit in CABG, especially in younger patients or those with multiple arterial graft requirements, on account of the excellent long-term patency rates this surgery has produced in contrast to the not-so-good one produced by vein grafts.

Analysis by End User

Based on End User, the market is divided into Hospitals, Specialty Clinics & Others

An increasing number of hospitals are realising the clinical and economic benefits of EVH compared to traditional open harvesting procedures; therefore, it will lead to overall market growth as hospitals are increasingly investing in these systems.

Speciality clinics are increasingly turning to EVH technology, as the technological capabilities of the EVH systems allow them to become increasingly streamlined and user-friendly, and as the scope of procedures that can be performed at outpatient settings increases.

Regional Analysis

To gain extensive insights into the market, Download for Customization

Based on region, the Endoscopic Vessel Harvesting market has been studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

The region of North America with the leading roles of the United States dominates the EVH market basically due to its well-advanced and high-tech healthcare system, strong healthcare spending levels, and the high rates of cardiovascular diseases. The area is characterized by a very high level of demand for the minimally invasive surgical techniques, and EVH is a far-went technique that is adopted by an extensive number of individuals because of its demonstrated advantages, fewer complications, and quicker recovery of patients in the case of such procedures as CABG.

• According to U.S. Centers for Disease Control and Prevention, there are 57000 cases per year of CABG surgeries using EVH techniques in U.S.
• According to American Hospital Association, 850 hospitals in U.S. performing EVH.

Europe is a developed and important market for EVH, with the high prevalence of cardiovascular diseases, developed healthcare systems and growing acceptance of minimally invasive surgeries. Other leading nations such as Germany, the UK, and France are presumed to be part of market expansion, and this has been occasioned by an increase in population age and an increase in the understanding of the superiority of EVH as compared to the traditional practices.

The Asia Pacific has been identified as the fastest-growing market for EVH and has great potential for future expansion. The main infrastructure that the growth is credited to includes a large and rapidly ageing population, which is a leading cause of the rising prevalence of cardiovascular diseases; the development of healthcare foundations and the growing healthcare spending within developing economies such as China and India; and growing awareness on both the part of the patient and the medical community of emerging surgical technology.

Key Players Covered

The report includes the profiles of the following key players:

• Terumo Corporation (Japan)
• Boston Scientific Corporation (Boston)
• Getinge (Sweden)
• LivaNova PLC (U.K.)
• Zimmer Biomet, Inc. (U.S.)
• AVOMA GROUP (U.S.)
• CardioPrecision Ltd. (U.K.)
• Med Europe European Medical Supplies SRL (Europe)

Key Industry Developments

• In March 2024, Getinge obtained United States FDA 510(k) clearance of its Vasoview Hemopro 3 Endoscopic Vessel Harvesting (EVH) system, which was another major step regarding minimally invasive surgical solutions.
• In September 2021, the company worked on launching its CoreVista 0,120 and CoreVista 1,300 device suites that would be utilized in Endoscopic Vessel Harvesting (EVH).
• In 2024, Getinge and its subsidiary Maquet Cardiovascular started a Class I recall of some of their VasoView HemoPro Endoscopic Vessel Harvesting (EVH) systems, the affected devices being models VasoView HemoPro 1 (VH-3000-W) and 1.5 (VH-3500), and subsequently corrected their VasoView HemoPro 2 (VH-4000 and VH-4001) devices.